Thompson Siegel & Walmsley’s MiMedx Group MDXG Stock Holding History

Thompson Siegel & Walmsley’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,615	Closed	-$458K	–	437
2025 Q4	$458K	Sell	67,615 -40,149	-37%	-$281K	0.01%	353
2025 Q3	$752K	Buy	107,764 +24,167	+29%	+$168K	0.01%	332
2025 Q2	$511K	Sell	83,597 -19,670	-19%	-$131K	0.01%	341
2025 Q1	$785K	Hold	103,267	–	–	0.01%	301
2024 Q4	$993K	Buy	103,267 +45,271	+78%	+$353K	0.02%	283
2024 Q3	$343K	Hold	57,996	–	–	0.01%	344
2024 Q2	$402K	Hold	57,996	–	–	0.01%	312
2024 Q1	$447K	Buy	57,996 +6,600	+13%	+$53K	0.01%	304
2023 Q4	$451K	Sell	51,396 -13,379	-21%	-$98K	0.01%	297
2023 Q3	$472K	Buy	64,775 +5,229	+9%	+$39K	0.01%	298
2023 Q2	$394K	Buy	+59,546	New	+$304K	0.01%	317

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Thompson Siegel & Walmsley's MDXG Position: Q1 2026 in Review

Thompson Siegel & Walmsley sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 67,615 shares — an estimated $458K sold.

Thompson Siegel & Walmsley first reported a position in MDXG in Q2 2023 and held it in 11 quarters. The position peaked at $993K in Q4 2024. 238 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

Thompson Siegel & Walmsley reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
Thompson Siegel & Walmsley sold 67,615 MiMedx Group shares in Q1 2026, an estimated $458K.
Thompson Siegel & Walmsley first reported a position in MiMedx Group in Q2 2023 and held it in 11 quarters.
Thompson Siegel & Walmsley's MiMedx Group position peaked at $993K in Q4 2024.
238 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2026, filed 11 May 2026.